Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.

MLA

Hellenbrand, Wiebke, et al. “Background Paper for the Update of Meningococcal Vaccination Recommendations in Germany: Use of the Serogroup B Vaccine in Persons at Increased Risk for Meningococcal Disease.” Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, vol. 58, no. 11–12, Nov. 2015, pp. 1314–43. EBSCOhost, https://doi.org/10.1007/s00103-015-2253-z.

APA

Hellenbrand, W., Koch, J., Harder, T., Bogdan, C., Heininger, U., Tenenbaum, T., Terhardt, M., Vogel, U., Wichmann, O., & von Kries, R. (2015). Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 58(11–12), 1314–1343. https://doi.org/10.1007/s00103-015-2253-z

Chicago

Hellenbrand, Wiebke, Judith Koch, Thomas Harder, Christian Bogdan, Ulrich Heininger, Tobias Tenenbaum, Martin Terhardt, Ulrich Vogel, Ole Wichmann, and Rüdiger von Kries. 2015. “Background Paper for the Update of Meningococcal Vaccination Recommendations in Germany: Use of the Serogroup B Vaccine in Persons at Increased Risk for Meningococcal Disease.” Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 58 (11–12): 1314–43. doi:10.1007/s00103-015-2253-z.